Leidos (LDOS) Jefferies Global Industrials Conference 2026 summary
Event summary combining transcript, slides, and related documents.
Jefferies Global Industrials Conference 2026 summary
9 Sep, 2026Strategic direction and growth pillars
NorthStar 2030 strategy focuses on five growth pillars: defense tech, energy infrastructure, cyber, mission and digital, and managed health services, with recent investments in energy and cyber capabilities.
Organic growth is accelerating, with 4% in Q2, 5% in the first half, and guidance raised to 8% for the second half, driven by defense tech, energy, and FAA modernization programs.
FAA modernization, including the Common Automation Platform, is a multi-billion dollar opportunity, expected to drive development and sustainment revenues over several years.
The IFPC program is scaling production, expected to double output by year-end, with significant growth anticipated in 2027.
ENTRUST acquisition doubled the energy business, expanded the addressable market by 3x, and is integrating technology for efficiency and new opportunities.
Segment performance and key programs
Health segment remains highly profitable, with the VBA medical disability exam program generating over $1 billion in revenue and strong margins, though incentive payments are paused until year-end.
VBA contract recompete may consolidate providers, with Leidos well-positioned due to coverage across all regions and sustained high exam volumes post-PACT Act.
MHS GENESIS program continues with a one-year extension; future scope may shift software licensing directly to vendors, but Leidos expects ongoing support and modernization roles.
Defense segment grew 6% in the quarter, with a 2.2x book-to-bill ratio, driven by IFPC, ABAD, and new awards in space and maritime unmanned surface vessels.
Homeland segment grew 32% (15% organic), supported by FAA, TSA, and international contracts, with margin improvement and further upside expected.
Financial outlook and capital allocation
Margins in health are moderating to about 20% in the second half due to incentive suspension, impacting overall company margins, but defense and homeland are expected to drive future margin growth.
CapEx for the year was revised down to $250 million, focusing on facility modernization and production capacity, with strong cash flow conversion expected.
Integration of ENTRUST is on track, with back office and leadership alignment expected by year-end, and technology adoption driving efficiency.
Portfolio strength allows for raised guidance despite health headwinds, with defense tech and energy businesses highlighted as underappreciated growth drivers.
Latest events from Leidos
- Q2 revenue up 7.2% to $4.56B, backlog at $48.7B, and FY26 guidance raised.LDOS
Q2 2026 - Revenue up 4% to $4.4B, guidance raised on strong demand and ENTRUST acquisition.LDOS
Q1 2026 - Key votes include board elections, executive pay, auditor ratification, and new incentive plans.LDOS
Proxy filing - Record revenue, robust governance, and new incentive plans highlight strong 2025 performance.LDOS
Proxy filing - Defense and energy segments drive double-digit growth, with AI and federal IT as key catalysts.LDOS
JPMorgan Industrials Conference 2026 - Double-digit EPS growth, strong cash flow, and major contract wins drive robust 2025 results.LDOS
Q4 2025 - Q3 revenue rose 7% to $4.47B, with raised guidance and strong backlog amid federal risks.LDOS
Q3 2025 - Q2 revenue up 7.7–8%, net income up 54%, and FY24 guidance raised for revenue and EPS.LDOS
Q2 2024 - Q1 2025 saw 7% revenue growth, margin expansion, and a $500M share repurchase.LDOS
Q1 2025